From Design House to Centers of Excellence: 369 Innovations’ Medical Manufacturing Play

February 8, 2026 Rishikesh Sahare 195 Views 3 min read

In a healthcare system where ideas die between PowerPoint slides and factory floors, 369 Innovations is building the missing bridge: turning medical concepts into manufacturable reality. Founded by Shruti Kushwaha, the company sits at the intersection of prototyping, contract manufacturing, and centers of excellence for global medical device firms. What began as a design experiment has evolved into a specialized engine for building patient-centric devices in India — with IP protection and industrial discipline at its core.

Why Manufacturing, Not Just Design

For decades, Indian innovators have struggled with a familiar problem: great ideas, no pathway to production. Kushwaha’s insight came from her own pivot — from pharmaceutical advisory roles into industrial design and finally into engineering-led device creation. Design alone, she discovered, could not sustain trust or scale. Manufacturing depth was the moat.

369 Innovations reframed the problem simply: if companies could test real products before investing in expensive tooling, innovation would move faster and fail cheaper.

Prototyping Without the Cost Trap

At its Center of Excellence in Ahmedabad, 369 Innovations produces 50–100 market-ready units without requiring costly molds or dies. These are not lab mockups — they are fully functional products meant for real customer testing. This intermediate scale allows startups and foreign firms to validate performance, usability, and demand before committing to mass manufacturing.

The model solves a critical gap in medical hardware: where one wrong tooling decision can lock in millions of rupees of mistakes.

India as a Trusted Second Factory

Rather than competing with China’s scale, 369 Innovations leans into India’s emerging trust advantage. Global device companies can establish parallel manufacturing lines in India — retaining IP ownership while reducing costs and gaining access to Asian markets.

The company handholds clients end-to-end:

Location scouting
R&D line setup
Batch manufacturing
Quality compliance
IP protection

It mirrors how consulting giants build Centers of Excellence — but applied to physical healthcare products.

Partnerships Over Ownership

Instead of building every factory in-house, 369 Innovations operates through a partner ecosystem:

Mechanical manufacturers
Electronics integration units
Clean-room facilities
Quality testing centers

This distributed model keeps capital light while maintaining production reliability. Electronics-first factories handle wiring and IoT integrations, while mechanical expansions scale faster and cheaper.

The strategy is pragmatic: build orchestration, not just machines.

Choosing a Focus: Patients and Hospitals

The company has concentrated on patient-centric and hospital devices — including telemedicine boxes, vein identification systems, and treatment-adjacent tools. Diagnostics is intentionally avoided: the regulatory and technical complexity outweighs strategic focus.

The bet is clear — depth over breadth, systems over SKUs.

Talent, Discipline, and Time

The journey has not been fast. Pandemic-era R&D, in-house machinery design, and early missteps in internships shaped a hard-earned lesson: core competence must be owned early. Without materials knowledge and process control, management alone cannot build a category.

Kushwaha’s approach now avoids high-churn training pipelines and focuses on retaining skilled operators who understand both engineering and healthcare compliance.

Why This Model Matters

India’s medical device ambition depends less on software dashboards and more on factories that can think. 369 Innovations is positioning itself as infrastructure — not a brand — enabling others to build safely, locally, and profitably.

In a sector obsessed with approvals and price, the company’s wedge is execution: turn ideas into tested hardware before capital is burned.

Call to Partners